Updating approach for lexicographic optimization-based planning to improve cervical cancer plan quality
-
Published:2023-09-30
Issue:1
Volume:14
Page:
-
ISSN:2730-6011
-
Container-title:Discover Oncology
-
language:en
-
Short-container-title:Discov Onc
Author:
Caricato Paolo,Trivellato Sara,Pellegrini Roberto,Montanari Gianluca,Daniotti Martina Camilla,Bordigoni Bianca,Faccenda Valeria,Panizza Denis,Meregalli Sofia,Bonetto Elisa,Voet Peter,Arcangeli Stefano,De Ponti Elena
Abstract
Abstract
Background
To investigate the capability of a not-yet commercially available fully automated lexicographic optimization (LO) planning algorithm, called mCycle (Elekta AB, Stockholm, Sweden), to further improve the plan quality of an already-validated Wish List (WL) pushing on the organs-at-risk (OAR) sparing without compromising target coverage and plan delivery accuracy.
Material and Methods
Twenty-four mono-institutional consecutive cervical cancer Volumetric-Modulated Arc Therapy (VMAT) plans delivered between November 2019 and April 2022 (50 Gy/25 fractions) have been retrospectively selected. In mCycle the LO planning algorithm was combined with the a-priori multi-criterial optimization (MCO). Two versions of WL have been defined to reproduce manual plans (WL01), and to improve the OAR sparing without affecting minimum target coverage and plan delivery accuracy (WL02). Robust WLs have been tuned using a subset of 4 randomly selected patients. The remaining plans have been automatically re-planned by using the designed WLs. Manual plans (MP) and mCycle plans (mCP01 and mCP02) were compared in terms of dose distributions, complexity, delivery accuracy, and clinical acceptability. Two senior physicians independently performed a blind clinical evaluation, ranking the three competing plans. Furthermore, a previous defined global quality index has been used to gather into a single score the plan quality evaluation.
Results
The WL tweaking requests 5 and 3 working days for the WL01 and the WL02, respectively. The re-planning took in both cases 3 working days. mCP01 best performed in terms of target coverage (PTV V95% (%): MP 98.0 [95.6–99.3], mCP01 99.2 [89.7–99.9], mCP02 96.9 [89.4–99.5]), while mCP02 showed a large OAR sparing improvement, especially in the rectum parameters (e.g., Rectum D50% (Gy): MP 41.7 [30.2–47.0], mCP01 40.3 [31.4–45.8], mCP02 32.6 [26.9–42.6]). An increase in plan complexity has been registered in mCPs without affecting plan delivery accuracy. In the blind comparisons, all automated plans were considered clinically acceptable, and mCPs were preferred over MP in 90% of cases. Globally, automated plans registered a plan quality score at least comparable to MP.
Conclusions
This study showed the flexibility of the Lexicographic approach in creating more demanding Wish Lists able to potentially minimize toxicities in RT plans.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Endocrine and Autonomic Systems,Endocrinology,Oncology,Endocrinology, Diabetes and Metabolism
Reference40 articles.
1. Hansen CR, Hussein M, Bernchou U, Zukauskaite R, Thwaites D. Plan quality in radiotherapy treatment planning - review of the factors and challenges. J Med Imaging Radiat Oncol. 2022;66(2):267–78. https://doi.org/10.1111/1754-9485.13374. 2. Hussein M, Heijmen BJM, Verellen D, Nisbet A. Automation in intensity modulated radiotherapy treatment planning - a review of recent innovation. Br J Radiol. 2018;91:20180270. https://doi.org/10.1259/bjr.20180270. 3. Heijmen B, Voet P, Fransen D, Penninkhof J, Milder M, Akhiat H, Bonomo P, Casati M, Georg D, Goldner G, Henry A, Lilley J, Lohr F, Marrazzo L, Pallotta S, Pellegrini R, Seppenwoolde Y, Simontacchi G, Steil V, Stieler F, Wilson S, Breedveld S. Fully automated, multi-criterial planning for volumetric modulated arc therapy- an international multi-center validation for prostate cancer. Radiother Oncol. 2018;128:343–8. 4. Cilla S, Ianiro A, Romano C, Deodato F, Macchia G, Buwenge M, Dinapoli N, Boldrini L, Morganti AG, Valentini V. Template-based automation of treatment planning in advanced radiotherapy: a comprehensive dosimetric and clinical evaluation. Sci Rep. 2020. https://doi.org/10.1038/s41598-019-56966-y. 5. Biston MC, Costea M, Gassa F, Serre AA, Voet P, Larson R, et al. Evaluation of fully automated a priori MCO treatment planning in VMAT for head-and-neck cancer. Phys Med. 2021;87:31–8. https://doi.org/10.1016/j.ejmp.2021.05.037.
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|